Sapporo Clinical Laboratory (TSE:9776) Cyclically Adjusted FCF per Share: 円-12.31 (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:9776 Sapporo Clinical Laboratory Inc TSE:9776
43 GF Score
Price 円1,960.00
GF Value 円1,041.47
! 4 Warning Signs
View Full Analysis

What is Sapporo Clinical Laboratory Cyclically Adjusted FCF per Share?

Sapporo Clinical Laboratory TSE:9776 43 Cyclically Adjusted FCF per Share is 円-12.31 as of Sep. 2025. GuruFocus rates TSE:9776 with a GF Score™ of 43/100 and a GF Value™ of 円1,041.47. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Sapporo Clinical Laboratory's adjusted free cash flow per share data for the fiscal year that ended in Mar. 2025 was 円-174.376. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is 円-12.31 for the trailing ten years ended in Mar. 2025.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -16.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Sapporo Clinical Laboratory was 20.00% per year. The lowest was -16.90% per year. And the median was -12.90% per year.

As of today (2026-08-05), Sapporo Clinical Laboratory's current stock price is 円 1960.00. Sapporo Clinical Laboratory's Cyclically Adjusted FCF per Share for the fiscal year that ended in Mar. 2025 was 円-12.31. Sapporo Clinical Laboratory's Cyclically Adjusted Price-to-FCF of today is .

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Sapporo Clinical Laboratory was 32.98. The lowest was 10.44. And the median was 13.00.


Sapporo Clinical Laboratory  (TSE:9776) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Sapporo Clinical Laboratory was 32.98. The lowest was 10.44. And the median was 13.00.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Sapporo Clinical Laboratory Cyclically Adjusted FCF per Share Related Terms


Sapporo Clinical Laboratory Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Sapporo Clinical Laboratory's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sapporo Clinical Laboratory Cyclically Adjusted FCF per Share Chart

Sapporo Clinical Laboratory Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.65 -10.19 -1.75 -1.68 -12.31

Sapporo Clinical Laboratory Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -1.68 0.00 -12.31 0.00

Sapporo Clinical Laboratory Cyclically Adjusted FCF per Share Competitor Comparison

For the Pharmaceutical Retailers subindustry, Sapporo Clinical Laboratory's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sapporo Clinical Laboratory Cyclically Adjusted Price-to-FCF vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Sapporo Clinical Laboratory's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Sapporo Clinical Laboratory's Cyclically Adjusted Price-to-FCF falls into.


TSE:9776
43GF Score
Sapporo Clinical Laboratory Inc TSE:9776
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sapporo Clinical Laboratory Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sapporo Clinical Laboratory's adjusted Free Cash Flow per Share data for the fiscal year that ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-174.376/111.1000*111.1000
=-174.376

Current CPI (Mar. 2025) = 111.1000.

Sapporo Clinical Laboratory Annual Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201603 126.088 97.900 143.089
201703 31.529 98.100 35.707
201803 285.853 99.200 320.144
201903 116.202 99.700 129.489
202003 -504.927 100.300 -559.296
202103 -676.381 99.900 -752.212
202203 183.576 101.100 201.734
202303 181.297 104.400 192.932
202403 189.108 107.200 195.988
202503 -174.376 111.100 -174.376

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of 円-12.31 mean?
Sapporo Clinical Laboratory (TSE:9776) has a Cyclically Adjusted FCF per Share of 円-12.31 as of Sep. 2025. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Sapporo Clinical Laboratory and its competitors.
Is Sapporo Clinical Laboratory's Cyclically Adjusted FCF per Share too high?
Sapporo Clinical Laboratory's current Cyclically Adjusted FCF per Share is 円-12.31. Overall, Sapporo Clinical Laboratory has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Sapporo Clinical Laboratory's Cyclically Adjusted FCF per Share compare to competitors?
Sapporo Clinical Laboratory's Cyclically Adjusted FCF per Share of 円-12.31 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted FCF per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Sapporo Clinical Laboratory and its competitors. Sapporo Clinical Laboratory's current Cyclically Adjusted FCF per Share is 円-12.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sapporo Clinical Laboratory stock overvalued right now?
Sapporo Clinical Laboratory (TSE:9776) has a current Cyclically Adjusted FCF per Share of 円-12.31. The stock's GF Value™ is 円1,041.47, compared to a current price of 円1,960.00 — trading 88.2% above its estimated fair value. The current Cyclically Adjusted FCF per Share is 円-12.31. Sapporo Clinical Laboratory's overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Sapporo Clinical Laboratory (TSE:9776), the current Cyclically Adjusted FCF per Share is 円-12.31 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sapporo Clinical Laboratory (TSE:9776) Overvalued in 2026?

Based on GuruFocus' analysis, Sapporo Clinical Laboratory stock appears to be overvalued. The current stock price of 円1,960.00 is trading 88.2% above its estimated GF Value™ of 円1,041.47.

Key valuation signals for TSE:9776:

  • Cyclically Adjusted FCF per Share: 円-12.31
  • GF Value™: 円1,041.47 vs. price of 円1,960.00 (88.2% above fair value)
  • GF Score™: 43/100 with 4 warning signs

No single metric tells the full story. See the TSE:9776 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sapporo Clinical Laboratory Business Description

Address 18-9-1 Nishi Kita-Gojo, Chuo-ku Sapporo, Hokkaido, Sapporo, JPN, 060 0005
Sapporo Clinical Laboratory Inc. is a Japan based company engaged in offering clinical testing services. Its portfolio of services covers clinical examination, pathological examination, dispensing pharmacy, food hygiene environmental test, and radiation management. It is also engaged in the development of an integrated system for clinical testing.
43GF Score

Get the complete analysis for TSE:9776

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,960.00
Price
円1,041.47
GF Value